Medplus Health Services Ltd

NSE: MEDPLUS · BSE: 543427 · Healthcare · 93 announcements

Share price: ₹643.00
Market cap: ₹7,725 Cr
Revenue (annual): ₹6,892 Cr
Net profit (annual): ₹219.7 Cr
P/E (TTM): 36.7×Sector 53.1×
Promoter holding: 40.19%-0.03% QoQ
FII holding: 14.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Adverse Business Impact 43 Legal & Regulatory 17 Other Announcement 5 Earnings Call 5 Management Change 4 Board Meeting Outcome 4 Board Meeting Date 3 Share Pledge 2 Financial Results 2 Capital Structure Change 2 Business Update 2 Annual General Meeting 2 Employee Stock Options 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

93 announcements with these filters

9 Apr 2026 18:05 IST NSE

Adverse Business Impact

Medplus Health Services Adverse Business Impact

MedPlus subsidiary Optival Health Solutions received a two-day drug license suspension order for a store in Jadcherla, Telangana. The suspension, effective from April 8, 2026, carries a negligible estimated revenue loss of ₹0.28 lacs (approximately ₹0.00 Crore) and follows alleged violations of the Drugs and Cosmetics Act, 1940.

Execution: 2 days

Read the filing ↗

6 Apr 2026 16:17 IST BSE

Other Announcement

Medplus Health Services Other Announcement

MedPlus Health Services Limited submitted its quarterly compliance certificate under SEBI (DP) Regulations for the period ended March 31, 2026. The certificate, issued by KFin Technologies, confirms that security details for dematerialized/rematerialized shares were furnished to stock exchanges.

Read the filing ↗

3 Apr 2026 16:53 IST NSE

Adverse Business Impact

Medplus Health Services Adverse Business Impact

MedPlus Health Services' subsidiary, Optical Health Solutions, received a two-day drug license suspension for its Jangaon, Telangana store. Issued by the Drugs Control Administration for Rule 65 violations, the suspension carries a negligible estimated revenue impact of ₹0.00 Crore (Rs 0.16 lacs).

Execution: 2 days

Read the filing ↗